Lazertinib (Step B-Stage 2)

About Lazertinib (Step B-Stage 2)

Lazertinib (Step B-Stage 2) is an impurity of Lazertinib carrying the CAS registry number 1903010-18-3 with a typical assay of 99.78%. Formula C11H15N3O4, molecular weight 253.25 g/mol. Its systematic (IUPAC) name is 2-methoxy-4-morpholin-4-yl-5-nitroaniline. Alternative names: 2-Methoxy-4-morpholino-5-nitroaniline.

It is supplied as a solid. Store the standard in its sealed vial, protected from light and moisture, and follow the storage condition printed on the COA. Good laboratory practice and suitable PPE are recommended during handling.

This Lazertinib impurity supports analytical method development and validation (AMV), batch release testing and the impurity sections of ANDA and DMF filings. It is used across pharmaceutical manufacturing and academic and industrial research.

Standard pack sizes are 10 mg, 25 mg, 50 mg and 100 mg, and every batch ships with a Certificate of Analysis (COA) and we export worldwide. This item is currently in stock for prompt dispatch.

Typical applications

Analytical method development
Method validation (AMV)
QC release testing
ANDA / DMF filings

Industries

Related to Lazertinib

View every impurity, metabolite and intermediate we list for Lazertinib.

Lazertinib impurities

Specifications & identifiers

Chemical identifiers
Product name	Lazertinib (Step B-Stage 2)
Catalogue No.	VQ-005135
CAS Number	1903010-18-3
IUPAC name	2-methoxy-4-morpholin-4-yl-5-nitroaniline
Molecular formula	C₁₁H₁₅N₃O₄
Molecular weight	253.25 g/mol
Exact mass	253.1063
Grade	Reference Standard
Purity / assay	99.78%
HSN code	38229090
InChIKey	YMIYWAWQAYMLPZ-UHFFFAOYSA-N
SMILES	COC1=CC(=C(C=C1N)[N+](=O)[O-])N2CCOCC2
PubChem CID	121269009

Physical properties
Physical form	Solid
LogP (XLogP3)	0.8
H-bond donors / acceptors	1 / 6
TPSA	93.5 Å²

Documents

Safety Data Sheet (SDS)16-section GHS · on request Certificate of AnalysisTypical / batch COA · on request Specification sheetTDS / MOA · on request

Frequently asked questions

What is the CAS number of Lazertinib (Step B-Stage 2)?

The CAS Registry Number of Lazertinib (Step B-Stage 2) is 1903010-18-3. It is also known as 2-Methoxy-4-(4-morpholinyl)-5-nitrobenzenamine, 2-Methoxy-4-morpholino-5-nitroaniline.

What is the molecular formula and molecular weight of Lazertinib (Step B-Stage 2)?

Lazertinib (Step B-Stage 2) has the molecular formula C11H15N3O4 and a molecular weight of 253.25 g/mol. Its IUPAC name is 2-methoxy-4-morpholin-4-yl-5-nitroaniline.

What is Lazertinib (Step B-Stage 2) used for?

Lazertinib (Step B-Stage 2) is supplied as a characterised reference material related to Lazertinib. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.

Which grade and pack sizes of Lazertinib (Step B-Stage 2) can I order?

We supply Lazertinib (Step B-Stage 2) in Reference Standard (99.78%) grade, in 10 mg, 25 mg, 50 mg, 100 mg, 250 mg, 500 mg packs. Larger bulk quantities and custom packing are quoted on request.

Do you provide a COA and SDS with Lazertinib (Step B-Stage 2)?

Yes. Every lot of Lazertinib (Step B-Stage 2) is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.

Can Lazertinib (Step B-Stage 2) be shipped internationally?

Yes. We export Lazertinib (Step B-Stage 2) worldwide by air and sea freight or express courier, on EXW, FOB, CIF, CFR or DAP Incoterms, with full export documentation.